Semi-Annual Consolidated Statement Of Comprehensive Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7550544

Concept 2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
676,000,000 JPY
1,183,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
285,000,000 JPY
997,000,000 JPY
Foreign currency translation adjustment
64,000,000 JPY
99,000,000 JPY
Remeasurements of defined benefit plans, net of tax
97,000,000 JPY
91,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
28,000,000 JPY
-4,000,000 JPY
Other comprehensive income
476,000,000 JPY
1,184,000,000 JPY
Comprehensive income
1,152,000,000 JPY
2,367,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,152,000,000 JPY
2,367,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.